Investor Relations

SEC Filings

Document Details

Form
Filing Date
Jul 05, 2022
Document Date
Jul 05, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.